NASDAQ:EFTR

Effector Therapeutics Stock Predictions

etoro logo Buy EFTR
*Your capital is at risk
$0.0006
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

EFTR Prediction Chart

EFTR Predictions History

Latest community submissions for EFTR.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 7, 2024 $16.15 -3.17% $14.99 V 92.25% 1
Mar 7, 2024 $16.35 -1.98% $14.99 V 90.93% 1
JS JS Pro
Mar 5, 2024 $17.29 +2.01% $15.57 X 88.95% 0
Mar 5, 2024 $16.64 -1.83% $15.57 V 93.13% 1
Mar 5, 2024 $16.45 -2.93% $15.57 V 94.32% 1
Mar 5, 2024 Bullish $15.57 X 0
JS JS Pro
Jun 29, 2023 $0.782 -95.90% $0.760 X 97.04% 0
Jun 29, 2023 $0.82 -95.70% $0.760 X 91.95% 0
Jun 29, 2023 $0.799 -95.81% $0.760 X 94.81% 0
Jun 20, 2023 $0.99 -95.72% $0.775 X 72.12% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EFTR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT EFFECTOR THERAPEUTICS, INC.
eFFECTOR Therapeutics
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE